Evidence map›Paper›PMID 42646285›Full record

ArticleMetabolites2026

A Metabolomics-Based Strategy for Identifying Endogenous Inhibitors of IAPP Aggregation.

Dandan Xia, Liubao Gu, Lei Yang, Jiaojiao Hu, Xiaowei Xu, Dechen Jiang, Qiuling Zheng, Bing Wan

Abstract read
In one paragraph

Article in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dandan XiaDepartment of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.ORCID 0000-0002-6208-1518
Liubao GuDivision of Clinical Epidemiology, Geriatric Hospital of Nanjing Medical University, Nanjing 210009, China.
Lei YangDepartment of Pharmaceutical Analysis, School of Pharmacy, China Pharmaceutical University, Tongjiaxiang #24, Nanjing 210009, China.
Jiaojiao HuDepartment of Pharmaceutical Analysis, School of Pharmacy, China Pharmaceutical University, Tongjiaxiang #24, Nanjing 210009, China.
Xiaowei XuInstitute of Innovative Drug Discovery and Development, China Pharmaceutical University, Tongjiaxiang #24, Nanjing 210009, China.ORCID 0000-0003-1886-2728
Dechen JiangThe State Key Lab of Analytical Chemistry for Life Science, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Qiuling ZhengDepartment of Pharmaceutical Analysis, School of Pharmacy, China Pharmaceutical University, Tongjiaxiang #24, Nanjing 210009, China.
Bing WanDepartment of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.

Funding

Jiangsu Provincial Science and Technology Plan Special Fund Key R&D Plan Social Development Project BE2023841
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IAPP aggregationmass spectrometrymetabolomic analysis

Identifiers

PMID42646285
PMCPMC13515482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.